Najważniejsze publikacje:

1. Relationship between serum transforming growth factor β 1 concentrations and the duration of type 1 diabetes mellitus in children and adolescents.
   Zorena K, Raczyńska D, Wiśniewski P, Malinowska E, Myśliwiec M, Raczyńska K, Rachoń D.
   Mediators Inflamm. 2013;2013:849457. PMID: 24222720
2. Biomarkers in diabetic retinopathy and the therapeutic implications.
   Zorena K, Raczyńska D, Raczyńska K.
   Mediators Inflamm. 2013;2013:193604. PMID: 24311895
3. Differential diagnosis of hyperandrogenism in women with polycystic ovary syndrome.
   Rachoń D.
   Exp Clin Endocrinol Diabetes. 2012 Apr;120(4):205-9. PMID: 22421986
4. Serum concentrations of transforming growth factor-Beta 1 in predicting the occurrence of diabetic retinopathy in juvenile patients with type 1 diabetes mellitus.
   Zorena K, Malinowska E, Raczyńska D, Myśliwiec M, Raczyńska K.
   J Diabetes Res. 2013;2013:614908. PMID: 23671881
5. Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS).
   Rutkowska A, Rachoń D.
   Gynecol Endocrinol. 2014 Jan 7. PMID: 24397396
6. Ovarian function and obesity—interrelationship, impact on women’s reproductive lifespan and treatment options.
   Rachoń D, Teede H.
   Mol Cell Endocrinol. 2010 Mar 25;316(2):172-9. PMID: 19818376
7. Threshold serum concentrations of tumour necrosis factor alpha (TNFα) as a potential marker of the presence of microangiopathy in children and adolescents with type 1 diabetes mellitus (T1DM).
   Zorena K, Kula M, Malinowska E, Raczyńska D, Myśliwiec M, Raczyńska K.
   Hum Immunol. 2013 Jan;74(1):75-81. PMID: 23073299